Cardiovascular health

Notes from SupplySide West 2018

Omega-3 trade group GOED ramps up healthcare practitioner outreach to better reach consumers

16-Nov-2018 By Adi Menayang

The fish oil industry’s leading trade group is tapping into the healthcare practitioner community as its bridge to consumers.

Recent large-scale omega-3s trials are harbingers of better days for omega-3s research, experts say

16-Nov-2018 By Hank Schultz

Despite the equivocal reports in the mainstream media of the recently released omega-3s trials, the huge statistical power of the studies means the promising secondary endpoints can be trusted, experts say.

Commentary

Choice of statistical framework colors answer to question of whether supplements actually work

16-Nov-2018 By Hank Schultz

Dietary supplements have held out the promise of greater health. Has the category delivered on that promise? Are people healthier now than they were decades ago?

Israeli startup debuts astaxanthin from yeast for human consumption

14-Nov-2018 By Hank Schultz

Israeli company NextFerm debuted an astaxanthin ingredient from a new source at the recent SupplySide West trade show.

ADM expands presence in algal DHA space with launch of powder form

13-Nov-2018 By Adi Menayang

Archer Daniels Midland Company, or ADM, launched a new powder format for its Onavita DHA algal oil.

VITAL and REDUCE-IT: Positive results and presentations around omega-3 for heart health

12-Nov-2018 By Stephen Daniells

New data from a couple of high profile and hotly anticipated trials indicate that omega-3 consumption may indeed significantly benefit a number of heart health outcomes. But the mainstream media coverage (and therefore messaging to consumers) has been...

Generational preferences affect engagement with dietary supplement brands: Survey

09-Nov-2018 By Stephen Daniells

Boomers want healthy aging products, Gen X-ers are interested in weight management, while Millennials are more interested in fitness: These are just three of the insights from a new analysis of 500,000 social media posts over 12 months.

Krill oil benefits point to omega-3 oils as effective in CVD risk

07-Nov-2018 By Will Chu

Krill-derived omega-3 fatty acids appear to reduce fasting levels of blood glucose, a Rimfrost-funded study finds, as researchers point to its supplementation as an effective approach in reducing cardiovascular disease (CVD) risk.

Evidence continues to build linking fiber supplementation and improved cholesterol levels

05-Nov-2018 By Adi Menayang

There’s mounting evidence that psyllium, oat bran beta-glucan, and PolyGlycopleX each confer blood lipid management benefits, but more studies are needed for the fibers’ effects on weight, hypertension, and blood sugar levels, researchers argued.

ABC bolsters traceability efforts with Sustainable Herbs Program partnership

05-Nov-2018 By Hank Schultz

The American Botanical Council has partnered with a noted documentary filmmaker to support the Sustainable Herb Program, which aims to foster transparency and traceability in the sourcing of the raw materials for increasingly popular herbal products.

Herbalife increasingly eyes Asia as growth engine of future

01-Nov-2018 By Hank Schultz

Herbalife’s global sales rose 15% in the third quarter. Record sales in China and the rest of Asia helped drive the result, and the company bucked recent trends in the multi-level marketing sector by posting sales increases in North America as well.

Vertical integration boosts traceability, quality of olive leaf extract, supplier maintains

01-Nov-2018 By Hank Schultz

Boundary Bend Wellness, a subsidiary of Australia’s largest olive oil producer, is planning on making a splash with its vertically integrated leaf extract ingredients at an upcoming trade show.

News in brief

Algarithm joins GOED’s Executive Council with $100,000 annual funding pledge

01-Nov-2018 By Stephen Daniells

Algarithm Ingredients has pledged $100,000 annually to GOED, putting the company on the omega-3 organization’s Executive Council on Education and Outreach (ECEO).

Amarin sues two omega-3s manufacturers, alleging they used company's drug trial to market supplements

31-Oct-2018 By Hank Schultz

Amarin Corporation, maker of EPA drug Vascepa, has sued two omega-3s finished good manufacturers for unfair trade practices for allegedly using the results of the company’s large scale drug trial to market their own fish-oil based dietary supplements.

Researchers take a closer look at which polyphenols may slash cardiovascular disease risk

30-Oct-2018 By Adi Menayang

Many studies have linked polyphenols—chemical compounds found in everything from chocolate to olives to berries—to reduced cardiovascular disease risk. French researchers took a closer look at how different types of polyphenols relate to this risk.